DK1966611T3 - Fremgangsmåde til opløsningstest af farmaceutiske produkter - Google Patents

Fremgangsmåde til opløsningstest af farmaceutiske produkter

Info

Publication number
DK1966611T3
DK1966611T3 DK06828761.4T DK06828761T DK1966611T3 DK 1966611 T3 DK1966611 T3 DK 1966611T3 DK 06828761 T DK06828761 T DK 06828761T DK 1966611 T3 DK1966611 T3 DK 1966611T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical products
dissolving pharmaceutical
dissolving
products
pharmaceutical
Prior art date
Application number
DK06828761.4T
Other languages
English (en)
Inventor
Anne Piechowicz Schwartz
Lise Smith Soerensen
Jan Soendergaard-Andersen
Original Assignee
Alk Abello As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alk Abello As filed Critical Alk Abello As
Application granted granted Critical
Publication of DK1966611T3 publication Critical patent/DK1966611T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK06828761.4T 2005-12-23 2006-12-22 Fremgangsmåde til opløsningstest af farmaceutiske produkter DK1966611T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US75371405P 2005-12-23 2005-12-23
DKPA200501828 2005-12-23
PCT/DK2006/000739 WO2007071257A1 (en) 2005-12-23 2006-12-22 Method for dissolution testing of pharmaceutical products

Publications (1)

Publication Number Publication Date
DK1966611T3 true DK1966611T3 (da) 2012-09-10

Family

ID=37907223

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06828761.4T DK1966611T3 (da) 2005-12-23 2006-12-22 Fremgangsmåde til opløsningstest af farmaceutiske produkter

Country Status (7)

Country Link
US (1) US7968351B2 (da)
EP (1) EP1966611B1 (da)
CN (1) CN101361000B (da)
CA (1) CA2634507A1 (da)
DK (1) DK1966611T3 (da)
HK (1) HK1120109A1 (da)
WO (1) WO2007071257A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010143860A (ja) * 2008-12-19 2010-07-01 Chisso Corp タンパク質の安定化剤
JP5931449B2 (ja) * 2012-01-11 2016-06-08 日東電工株式会社 医薬組成物及びその製造方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4225730C2 (de) * 1992-08-04 2003-04-30 Merz Pharma Gmbh & Co Kgaa Verfahren zur Herstellung von festen Arzneiformkörpern mit protrahierter 2-Stufen-Freisetzung
CA2251129A1 (en) * 1996-05-03 1997-11-13 Innogenetics N.V. New medicaments containing gelatin cross-linked with oxidized polysaccharides
AU2003280324A1 (en) 2002-11-26 2004-06-18 Alk-Abello A/S Pharmaceutical allergen product
US20040115837A1 (en) 2002-11-27 2004-06-17 Schapaugh Randal Lee Methods of measuring the dissolution rate of an analyte in a non-aqueous liquid composition
US7024955B2 (en) 2003-03-01 2006-04-11 Symyx Technologies, Inc. Methods and systems for dissolution testing
EP1596199A1 (en) 2004-05-14 2005-11-16 Prionics AG Method for the detection of disease-related prion

Also Published As

Publication number Publication date
US20080305505A1 (en) 2008-12-11
CN101361000A (zh) 2009-02-04
WO2007071257A8 (en) 2008-09-18
CA2634507A1 (en) 2007-06-28
EP1966611A1 (en) 2008-09-10
HK1120109A1 (en) 2009-03-20
WO2007071257A1 (en) 2007-06-28
US7968351B2 (en) 2011-06-28
CN101361000B (zh) 2013-04-17
EP1966611B1 (en) 2012-07-25

Similar Documents

Publication Publication Date Title
DK2058020T3 (da) Indretning til indgivelse af lægemiddel
DK1942967T3 (da) Fremgangsmåde til dosering af medikamenter
DK1957073T3 (da) Lægemiddel
DK2124999T3 (da) Activin-actrii antagonister og anvendelser til behandling af anæmi
DK2073795T3 (da) Misbrugssikret lægemiddelformulation
CY2012027I1 (el) Μεθοδος βιομηχανικης κατασκευης εμβολιων
DK1928503T3 (da) Fremgangsmåde til fremstilling af oprensede lægemiddelkonjugater
DK1983964T3 (da) Anordning til indgivelse af lægemiddel
DK1893586T3 (da) Fremgangsmåde til fremstilling af 1-alkyl-3-phenyluraciler
DE602006007875D1 (de) Kapseln
NO20075628L (no) Farmasøytiske formuleringer
DE602007006324D1 (de) Insektizide n-substituierte (heteroaryl) cycloalkylsulfoximine
DK2120604T3 (da) Fremgangsmåde til fraktionering af havre, produkter derved opnået, og anvendelser deraf
DK1510809T3 (da) Indretning til inspektion af produkter
DE602006020744D1 (de) Fertigspritze
DK1757293T3 (da) Bh4-responsiv hyperphenylalaninæmi-medikamenter
DK1910325T3 (da) Nye farmaceutisk forbindelser
DE602006018590D1 (de) Heteroarylharnstoffderivate zur hemmung von chk1
DK1919290T3 (da) Fremgangsmåder og produkter til behandling af sygdomme
DK2172207T3 (da) Farmaceutisk sammensætning til behandling af diabetes og fremgangsmåde til fremstilling heraf
DK2390326T3 (da) Fremgangsmåde til fremstilling af et humant type II-collagen
DK1912961T3 (da) Fremgangsmåde til fremstilling af bepromolin
ATE540672T1 (de) Pharmazeutische zusammensetzung und verfahren
DK1966611T3 (da) Fremgangsmåde til opløsningstest af farmaceutiske produkter
DK2216039T3 (da) Farmaceutiske sammensætninger til behandling af angst